HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,461 | -6.3% | 38,259 | -6.3% | 0.04% | -5.4% |
| Q1 2023 | $1,560 | -99.1% | 40,839 | +308.4% | 0.04% | +208.3% |
| Q4 2015 | $173,000 | +29.1% | 10,000 | 0.0% | 0.01% | +100.0% |
| Q3 2015 | $134,000 | -39.6% | 10,000 | -42.9% | 0.01% | +50.0% |
| Q1 2014 | $222,000 | -65.1% | 17,500 | -58.8% | 0.00% | -71.4% |
| Q4 2013 | $637,000 | +44.1% | 42,480 | +6.2% | 0.01% | +180.0% |
| Q3 2013 | $442,000 | – | 40,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |